636
A. Defant et al.
water and dichloromethane, the organic phases were sep-
arated (93), combined and washed in sequence with 0.5 M
aq. HCl, saturated solution of NaHCO3 and water, dried on
anhydrous Na2SO4 and concentrated in vacuo. The residue
was subjected to flash-chromatography on silica gel with
hexane/EtOAc gradient elution, to give tosylate 6 as
a viscous yellowish oil (552 mg, 88%).
of Eu(tfc)3 in CDCl3 was added by 1–30 ll portions,
observing proton shifts without splitting of the signals.
After the addition of 0.30 mol equiv of shift-reagent Dd
for the signals of the protons were: 2.79 (OH), 0.79 (H-5),
0.75 and 0.73 (2H-4), 0.67 and 0.65 (2H-2), 0.59 and 0.37
(2H-6), 0.42 ppm (OMe).
(3R,5S)-5-(Azidomethyl)-3-hydroxytetrahydrofuran-3-car-
boxylic acid (8) To a solution of 7 (146 mg, 0.725 mmol)
in THF (5 ml) was added NaOH 0.5 M (1.5 ml,
0.363 mmol) and stirred for 3 h. The mixture was passed
through a column of Amberlyst 15 (H-form), washing with
acetonitrile and water. The eluate, having a pH value of 4,
was evaporated in vacuo to give the acid 8 (135 mg, 99%),
pure enough to be used in the next step.
[a]2D0 = ?19.7 (c 0.04, CH2Cl2). 1H NMR (CDCl3):
d 7.80 (2H, d, J = 8.4 Hz, H-20 and H-60), 7.33 (2H, d,
J = 8.4 Hz, H-30 and H-50), 4.39 (1H, m, H-5), 4.15 (1H, dd,
J = 10.6, 3.8 Hz, H-6), 4.10 (1H, dd, J = 10.6, 4.8 Hz,
H-6), 4.09 (1H, d, J = 9.9 Hz, H-2), 3.81 (3H, s, OMe), 3.77
(1H, d, J = 9.9 Hz, H-2), 3.38 (1H, br. s, OH), 2.44 (3H, s,
Me-40), 2.23 (1H, dd, J = 12.8, 9.9 Hz, H-4), 2.09 (1 H, dd,
J = 12.8, 6.0 Hz, H-4). 13C NMR (CDCl3): d 174.3 (COO),
146.7 (C-10), 144.9 (C-40), 129.8 (C-30and C-50), 127.9 (C-20
and C-40), 81.0 (C-3), 78.2 (C-5), 76.6 (C-2), 70.1 (C-6),
53.4 (OMe), 41.5 (C-4), 21.6 (q, Me-40). Significant HMBC
correlations: d 7.80 ppm (H-20 and H-60) with C-10; 7.33
(H-30 and H-50) with Me-40; 4.15 (H-6) with C-4, 4.09 (H-2)
with COO, 3.81 (OMe) with C-3 and COO, 3.77 (H-2) with
COO, 2.09 (H-4) with C-3 and C-5. ESIMS (positive mode):
m/z 353 ([M ? Na]?), 331 ([M ? H]?); ESI–MS/MS
(331): 159([M ? H - TsO]?).
White powder. [a]2D0 = ?87.4 (c 0.2, EtOH). H NMR
1
(CDCl3): d 4.45 (1H, m, H-5), 4.30 (1H, d, J = 9.6 Hz,
H-2), 3.90 (1H, d, J = 9.6 Hz, H-2), 3.85 (1H, s, HO-3),
3.55 (1H, dd, J = 12.8, 3.5 Hz, H-6), 3.36 (1H, dd, J =
12.8, 5.6 Hz, H-6), 2.37 (1H, dd, J = 12.9, 9.8 Hz, H-4),
2.16 (1H, dd, J = 12.9, 5.8 Hz, H-4).13C NMR (CDCl3):
d 177.5 (COOH), 83.3 (C-3), 78.8 (C-2), 78.3 (C-5), 53.1
(C-6), 42.2 (C-4). Significant HMBC correlations:
d 4.30 ppm (H-2) with C-4, C-5 and COO; dH 3.90
(H-2) with C-4, C-5 and COO; 3.55 and 3.36 (2H-6) with
C-4 and C-5; 2.37 (H-4) with C-2, C-6 and COO. ESIMS
(negative mode): m/z 186 ([M–H]-).
(3R,5S)-Methyl 5-(azidomethyl)-3-hydroxytetrahydrofuran-
3-carboxylate (7) A mixture of tosylate 6 (552 mg,
1.67 mmol), sodium azide (163 mg, 2.5 mmol) and
Aliquatꢂ 336 (101 mg, 0.25 mmol) in anhydrous acetonitrile
(20 ml) was refluxed for 17 h. After cooling and filtration,
the solvent was removed in vacuo and the residue was
subjected to flash-chromatography on silica gel with
hexane/EtOAc gradient elution, to give the azide 7 as
viscous clear oil (292 mg, 87%).
(1R,5S)-1-hydroxy-6-oxa-3-azabicyclo[3.2.1]octan-2-one(9)
A solution of 7 (73 mg, 0.36 mmol) in 5 ml of ethanol was
hydrogenated for 3 h at room temperature and atmospheric
pressure in presence of 10% Pd/C. After filtration, the
solvent was evaporated in vacuo to obtain compound 9
(38 mg, 73%).
1H NMR (CDCl3): d 5.50 (1H, br. s, NH), 4.56 (1H, br.
s, H-5), 4.00 (1H, d, J = 8.0 Hz, H-2), 3.73 (1H, d,
J = 8.0 Hz, H-2), 3.46 (1H, d, J = 12.6 Hz, H-6), 3.36
(1H, d, J = 12.6, H-6), 2.50 (1H, dd, J = 11.9, 5.7 Hz,
H-4), 2.06 (1H, br. d, J = 11.8 Hz, H-4).13C NMR
(CDCl3): d 175.0 (CONH), 85.0 (C-3), 74.5 (C-5), 73.3
(C-2), 45.2 (C-6), 54.0 (C-4). Significant HMBC correla-
tions: d 4.00 and 3.73 ppm (2H-2) with C-5 and C=O; 2.06
(H-4) with C=O. ESIMS (positive mode): m/z 144
([M ? H]?), 166 ([M ? Na]?).
[a]2D0 = ?90.3 (c 0.06, MeOH). 1H NMR (CDCl3):
d 4.40 (1H, m, H-5), 4.23 (1H, d, J = 9.5 Hz, H-2), 3.85
(3H, s, OMe), 3.83 (1H, d, J = 9.5 Hz, H-2), 3.54 (1H, dd,
J = 12.8, 3.6 Hz, H-6), 3.40 (1H, br. s, OH), 3.31 (1H, dd,
J = 12.8, 5.6 Hz, H-6), 2.28 (1H, dd, J = 12.8, 9.9 Hz,
H-4), 2.08 (1H, dd, J = 12.8, 5.4 Hz, H-4).13C NMR
(CDCl3): d 174.4 (COO), 77.8 (C-5), 81.6 (C-3), 78.2
(C-2), 53.3 (OMe), 53.2 (C-6), 53.3 (OMe), 42.3 (C-4).
Significant HMBC correlations: d 3.85 ppm (H-2) with
C-4; 4.23 (H-2) with C-4, C-5 and C-4 COO, 3.85 (OMe)
with COO, 4.40 (H-5) with C-2, C-6 and C-4, 3.54 (H-6)
with C-4 and C-5; 3.31 (H-6) with C-2 and C-4; 2.28 (H-4)
with C-6, C-2 and COO; 2.08 (H-4) with C-2. Significant
HMBC correlations: d 4.23 ppm (H-2) with C-5 and COO;
3.83 (H-2) with C-3, C-5 and COO; 3.54 (H-6) with C-4,
C-5; 2.28 (H-4) with C-2, C-6,COO; 2.08 (H-4) with C-3.
ESIMS (positive mode): m/z 224 ([M ? Na]?).
((2S,4R)-4carboxy-4-hydroxytetrahydrofuran-2-yl) methana-
minium salt A solution of 8 (135 mg, 0.72 mmol) in
10 ml of ethanol was hydrogenated for 3 h at room tem-
perature and atmospheric pressure in presence of 10% Pd/
C. After filtration, the solvent was evaporated in vacuo to
obtain 4, as protonated form due to the acid condition of
the starting reagent (110 mg, 95%).
White crystalline solid, m.p. 192–194ꢁC. [a]2D0 = ?24.3
(c 0.15, H2O). IR mmax: 2,910 (v br) 1,716 (vs), 1,591 (s),
Chiral shift-reagent study with 7 To compound 7
(2.0 mg, 0.01 mmol) in 0.5 ml of CDCl3 a 0.11 M solution
123